IFN-γ Low Production Capacity in Type 1 Diabetes Mellitus Patients at Onset of Disease

Abstract

In type 1 diabetes mellitus (T1DM), cytokines can be directly cytotoxic to β-cells, and/or play an indirect role influencing some cells of the immune system. Since several factors could impair cytokine serum levels, the purpose of our study was to longitudinally evaluate intracellular cytokines, in T1DM patients, and in subject at risk, by flow cytometry analysis. At T1DM onset we observed significantly lower percentage of peripheral CD4 + and CD8 + cells producing IFN-γ in patients compared to controls and subjects at risk. The 15-month follow-up patients showed significantly lower percentage of CD4 + and CD8 + cells producing IFN-γ compared to the other groups. At 8-year follow-up no significant differences were observed among the groups in the percentage of cells producing cytokines. We could have considered “exhausted cells” or these T cell subsets may be migrated from peripheral blood to pancreas. On the other hand, our results are in agreement with those reported in literature: in animal model the absence of IFN-γ production makes β-cells highly susceptible to viral infection and subsequent attack by natural killer cells, which lead to hyperglycaemia and diabetes mellitus.

Key words

T1DM - cytokines - IFN-γ - CD4 + - CD8 +

References

• 1 Barnett A H, Eff C, Leslie R D, Pyke D A. Diabetes in identical twins. A study of 200 pairs.  Diabetologia. 1981;  20 87-93
• 2 Casares S, Brumeanu T D. Insights into the pathogenesis of type 1 diabetes: a hint for novel immunospecific therapies.  Curr Mol Med. 2001;  1 357-378
• 3 Cetkovic-Cvrlje M, Eizirik D L. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide.  Citokine. 1994;  6 399-406
• 4 Couper J J. Environmental triggers of type 1 diabetes.  J Paediatr Child Health. 2001;  37 218-222
• 5 Devendra D, Liu E, Eisenbarth G S. Type 1 diabetes: recent developments.  BMJ. 2004;  328 750-754
• 6 Eisenbarth G S. Type 1 diabetes mellitus. A chronic autoimmune disease.  N Engl J Med. 1986;  314 1360-1368
• 7 Falcone M, Sarvetnick N. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus.  Clin Immunol. 1999;  90 2-9
• 8 Flodstrom M, Maday A, Balakrishna D, Cleary M M, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection.  Nat Immunol. 2002;  3 373-382
• 9 Foulis A K, Farquharson M A, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.  Lancet. 1987;  2 1423-1427
• 10 Foulis A K, McGill M, Farquharson M A. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes, and interferon-γ containing cells.  J Pathol. 1991;  165 97-103
• 11 Halminen M, Simell O, Knip M, Ilonen J. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and in subjects positive for diabetes-associated autoantibodies.  Scand J Immunol. 2001;  53 510-513
• 12 Huang X, Yuan J, Goddard A, Foulis A, James R F, Lernmark A, Pujol-Borrel R, Rabinovitch A, Somoza N, Stewart T A. Interferon expression in the pancreas of patients with type 1 diabetes.  Diabetes. 1995;  44 658-664
• 13 Hyoty H, Taylor K W. The role of viruses in human diabetes.  Diabetologia. 2002;  45 1353-1361
• 14 Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry.  J Immunol Methods. 1993;  159 197-207
• 15 Katz J D, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes.  Science. 1995;  268 1185-1188
• 16 Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S. Multiple immuno-regulatory defects in type-1 diabetes.  J Clin Invest. 2002;  109 131-140
• 17 Kumar D, Gemayel N S, Deapen D, Kapadia D, Yamashita P H, Lee M, Dwyer J H, Roy-Burman P, Bray G A, Mack T M. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin.  Diabetes. 1993;  42 1351-1363
• 18 Kyvik K O, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus. A population based study of young Danish twins.  Br Med J. 1995;  311 913-917
• 19 Liblau R S, Singer S M, McDevitt H O. Th1 and Th2 CD4 + T cells in the pathogenesis of organ-specific autoimmune diseases.  Immunol Today. 1995;  16 34-38
• 20 Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 h.  Tissue Antigens. 1993;  41 119-134
• 21 Rabinovitch A. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction.  Diabetes Rev. 1993;  1 215-240
• 22 Redondo M J, Gottlieb P A, Motheral T, Mulgrew C, Rewers M, Babu S, Stephens E, Wegmann D R, Eisenbarth G S. Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for Type 1 A Diabetes.  Diabetes. 1999;  48 2166-2170
• 23 Roep B O, De Vries R R. T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus.  Eur J Clin Invest. 1992;  22 697-711
• 24 Soldevila G, Buscema M, Doshi M, James R F, Bottazzo G F, Pujol-Borrell R. Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells.  J Autoimmun. 1991;  4 291-306
• 25 Suarez-Pinzon W, Rajotte R V, Mosmann T R, Rabinovitch A. Both CD4 + and CD8 + T cells in syngenic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.  Diabetes. 1996;  45 1350-1357
• 26 Thomas H E, Parker J L, Schreiber R D, Kay T WH. IFN-γ action on pancreatic beta cells causes class I MHC upregulation but not diabetes.  J Clin Invest. 1998;  102 1249-1257
• 27 Videbaek N, Harach S, Phillips J, Hutchings P, Ozegbe P, Michelsen B K, Cooke A. An islet-homing NOD CD8 + cytotoxic T cell clone recognizes GAD 65 and causes insulitis.  J Autoimmunity. 2003;  20 97-109
• 28 Wang B, Andrè I, Gonzales A, Katz J D, Aguet M, Benoist C, Mathis D. Interferon γ impacts at multiple points during the progression of autoimmune diabetes.  Proc Natl Acad Sci USA. 1997;  94 13844-13849